AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Johnson Matthey PLC

Business and Financial Review Nov 24, 2021

4899_rns_2021-11-24_97dfbe58-7e88-4a2a-83df-8ea189d35456.html

Business and Financial Review

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 3397T

Johnson Matthey PLC

24 November 2021

24th November 2021

Johnson Matthey Plc

(the Company)

Johnson Matthey announces sale of Advanced Glass Technologies

·    Johnson Matthey announces the sale of its Advanced Glass Technologies business to Fenzi Holdings SPV S.p.A for £178 million on a cash free debt free basis.

·       Completion anticipated in spring 2022.

Johnson Matthey (JM) today announces the sale of its Advanced Glass Technologies (AGT) business, a leading global provider of specialist glass enamels and precious metal pastes supplied mainly to the automotive sector. AGT is part of Value Businesses in JM's 'Other Markets' segment and was previously identified as non-core to JM's growth strategy.

AGT will be sold to Fenzi Holdings SPV S.p.A ("Fenzi Group"), a manufacturer and supplier of materials for flat glass processing, for £178 million payable in cash at completion on cash free, debt free basis and subject to customary completion accounts adjustments.

The transaction is subject to works council consultation in the Netherlands and the satisfaction of customary completion conditions with completion expected in spring 2022.

In the year ended 31st March 2021, AGT generated sales excluding precious metals of £66 million, operating profit of £17 million and gross asset of £49 million. A profit on sale in excess of £100 million is expected. In line with our capital allocation framework, we will return the sale proceeds to shareholders as part of the £200 million share buyback programme commencing in the New Year.

The divestment of AGT is consistent with our aim of creating a simpler, more focused portfolio. Aligned with JM's strategy, the company is focusing its resources towards growth areas targeted at climate change solutions as it delivers on its vision for a cleaner, healthier world.

About Johnson Matthey

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, we improve the performance, function and safety of our customers' products. Our science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet's natural resources. Today more than 15,000 Johnson Matthey professionals collaborate with our network of customers and partners to make a real difference to the world around us. For more information, visit www.matthey.com

ENDS

Enquiries:
Investor Relations

Martin Dunwoodie

Louise Curran

Jane Crosby
Director of Investor Relations

Senior Investor Relations Manager

Investor Relations Manager
020 7269 8241

020 7269 8235

020 7269 8242
Media

Barney Wyld

Harry Cameron
Group Corporate Affairs Director

Tulchan Communications
020 7269 8001

07799 152 148

Johnson Matthey Plc is listed on the London Stock Exchange (JMAT)

Registered in England & Wales number: 00033774

Legal Entity Identifier number: 2138001AVBSD1HSC6Z10

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DISBXLLLFFLLFBL

Talk to a Data Expert

Have a question? We'll get back to you promptly.